McMeekin, D. S., Sill, M. W., Walker, J. L., Moore, K. N., Waggoner, S. E., Thaker, P. H., . . . Fracasso, P. M. (2015). A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol.

McMeekin, D Scott, Michael W. Sill, Joan L. Walker, Kathleen N. Moore, Steven E. Waggoner, Premal H. Thaker, Tina Rizack, James S. Hoffman, and Paula M. Fracasso. "A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients At High Risk for Peritoneal Failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2015.

McMeekin, D Scott, et al. "A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients At High Risk for Peritoneal Failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2015.